Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
about
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticlesAdvancements in the delivery of epigenetic drugsAn Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish embryosAssessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion.Chinese Herbal Mixture, Tien-Hsien Liquid, Induces G2/M Cycle Arrest and Radiosensitivity in MCF-7 Human Breast Cancer Cells through Mechanisms Involving DNMT1 and Rad51 Downregulation.Multidrug-resistant breast cancer: current perspectives.Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.Epigenetic reprogramming in breast cancer: from new targets to new therapies.Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer.Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.Combined treatment with low concentrations of decitabine and SAHA causes cell death in leukemic cell lines but not in normal peripheral blood lymphocytesSynergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effectScaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACsParthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2.Mussel-Inspired Protein Nanoparticles Containing Iron(III)-DOPA Complexes for pH-Responsive Drug Delivery.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation.Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor in colon cancer cellsEffects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines
P2860
Q27026080-2B4823E2-D432-4987-A910-0CCC0D675534Q28088478-13F109BA-D2EB-4FCC-B162-2D038DEDEF50Q33580906-D4742E56-46F0-42D6-9A34-0F892C9B74D9Q34999653-6BC6844E-32B4-4727-B716-26F6E91BC58DQ35845089-C3123DD0-FD0C-44F7-BF6B-79DBED0DE356Q36194410-5D493B90-9DCF-4398-A716-074E482C013BQ36200052-BE5DF890-086F-405D-8710-897BDEA544D2Q36213062-34B921F7-2F29-4F82-BABE-7D6BB87CCC43Q36609590-84F76F55-D879-4EA3-ACF3-BD5450ECFB16Q37147428-E10B82C3-C900-4EBC-9454-74A7514A34A5Q37593383-FFBDE3B9-3F3D-4669-BB89-6CA00297D8BDQ37680216-B0FB8D65-7E7C-4320-A43A-7C3F39D40B29Q38233472-5FCFA28C-944B-4C23-B354-E7E626C5F8D4Q38741165-7CD2DE2D-3722-451D-BFEC-7D50274F1F20Q38828009-B59165C4-F566-4A3E-87B8-D9AC016F48FBQ38854876-69F0CA70-59F8-4902-8991-026642B6F2F9Q39100888-FDEE69C8-3A79-4671-848C-4DA61D19D2E2Q41194522-E7E421B4-1C80-4DF8-AA55-7C28A2603697Q41664988-84E20949-FAC1-48EE-9C4E-7B153F7CA9D5Q42680055-46D645B0-9359-4179-B1F4-51230A04D4FFQ49193135-998BFBC8-8FD3-4A10-B4D5-777C8F821B1BQ50977730-D0F1A08D-5F4A-457E-8C99-EFE10676E4C5Q52597632-74FF943A-6727-461B-81EA-223C59543338Q53059153-4CD48A52-56A3-4DEF-B58D-14A78C920422Q58697697-D05ED6F1-CB51-4217-A69D-7E20C4A056B9Q58776042-82BDDCB0-1ECF-4EDB-B36F-4456066E035A
P2860
Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@ast
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@en
type
label
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@ast
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@en
prefLabel
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@ast
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@en
P2093
P2860
P356
P1476
Highly synergistic effect of s ...... leading to G2/M cycle arrest.
@en
P2093
Josephine Kamtai Dermawan
Sivakumar Vijayaraghavalu
Venugopalan Cheriyath
Vinod Labhasetwar
P2860
P304
P356
10.1021/MP3004622
P407
P577
2012-12-24T00:00:00Z